Drug intelligence / Profile preview

glutamate + aspartate

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral (nutritional Supplement), Experimental Local Application (e.g., Bath/iontophoretic Application In Research)
01

Overview

Glutamate + aspartate is a combination of two naturally occurring amino acids, glutamic acid (glutamate) and aspartic acid (aspartate). Both are classified as excitatory amino acids and serve critical roles in cellular metabolism, neurotransmission, and protein synthesis. In the nervous system, both act as neurotransmitters—most notably glutamate, which is the primary excitatory neurotransmitter in vertebrates. Aspartate also has excitatory properties but is less potent than glutamate. Experimental studies have shown that when administered together to neuromuscular tissue (such as lobster muscle fibers), they can induce membrane depolarization more effectively than either alone due to cooperative or synergistic interactions at receptor sites. This synergy may be due to increased affinity of glutamate for its receptors in the presence of aspartate or through summation effects at postsynaptic membranes[1][2]. In animal nutrition research, supplementation with both amino acids (often alongside glutamine) supports intestinal barrier function and energy homeostasis[5]. There are no known pharmaceutical products marketed specifically under this combination for human use; their main uses are nutritional or experimental.

Other names
glutamic acid + aspartic acidL-glutamate + L-aspartate
02

Targets

AMPAR (AMPA receptor)Kainate-type ionotropic glutamate receptorNMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on glutamate + aspartate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glutamate + aspartate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call